PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35468939-7	2022	Gefitinib and Osimertinib medications were capable of upregulating KLHDC3 expression to promote p14ARF degradation in the NSCLC cell lines.	osimertinib	14-25	cyclin dependent kinase inhibitor 2A	Homo sapiens	96-102